Similar companies
Did INmune Bio Beat Earnings?
INmune Bio (INMB) reported Q2 '26 revenue of $0.
AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — INmune Bio’s job postings, web traffic, and employee business outlook. See the full INMB stock analysis or the earnings calendar for upcoming reports.
INmune Bio Quarterly Financial Trends
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 50,000 | — | — | — | — | — |
| Gross margin | — | — | 100.0% | — | — | — | — | — |
| Operating margin | — | — | -19,810.0% | — | — | — | — | — |
| Net income | -12M | -9.2M | -9.7M | -24M | -6.5M | -5.3M | -5.4M | -1.3M |
| Net margin | — | — | -19,478.0% | — | — | — | — | — |
| EPS | — | — | — | — | — | — | — | — |
INmune Bio Earnings Trend Analysis
Over the eight quarters from Q3 '24 to Q2 '26, INmune Bio’s quarterly revenue moved from $0 to $0.
When Is INmune Bio’s Next Earnings Date?
INmune Bio reports earnings on a quarterly schedule. Its most recent report covered Q2 '26. For the confirmed upcoming date — and every other company reporting soon — see the INMB earnings calendar.
Frequently Asked Questions: INmune Bio Earnings
INmune Bio's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.
INmune Bio reported Q2 '26 revenue of $0.
Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the INMB AI Score.
